跳至主要内容
临床试验/IRCT201512144786N3
IRCT201512144786N3已完成3 期

The comparison of the effect of intravitreal Bevacizumab (Avastin) injection alone or in combination with Diclofenac on the visual acuity of patients with diabetic macular edema

Isfahan University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with these criteria were enrolled: diagnosed as center involving diabetic macular edema (DME), have no history of previous surgery, intraocular injection, diagnosis of glaucoma or ocular hypertension, visual acuity between 20/320 to 20/40, absence of iris neovascularization and significant opacities of ocular media, who are not monocular and are not pregnant. The exclusion criteria were: any previous hypersensitivity reaction to Bevacizumab or Diclofenac, complications such as endophthalmitis or intraocular pressure rise, refusal of patient or his/her non-cooperation in follow ups.

排除标准

  • 未提供

研究者

相似试验